The effect of the antiestrogen tamoxifen on bone mineral density in normal late postmenopausal women

American Journal of Medicine

Volumn 99, Issue 6, 1995, Pages 636-641

  Grey, Andrew B ^a   Stapleton, Joanne P ^a   Evans, Margaret C ^a   Tatnell, Michele A ^a   Ames, Ruth W ^a   Reid, Ian R ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ANTIESTROGEN; CALCIUM ION; HYDROXYPROLINE; PHOSPHATE; PLACEBO; TAMOXIFEN;

ABSORPTIOMETRY; ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BONE DENSITY; BONE METABOLISM; BONE MINERAL; BONE TURNOVER; CALCIUM BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; FEMUR NECK; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; PHOSPHATE BLOOD LEVEL; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; URINARY EXCRETION; VAGINA DISCHARGE;

EID: 0029559180     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(99)80251-4     Document Type: Article

References (36)

1. Pathogenesis of osteoporosis
2. Long-term prevention of postmenopausal osteoporosis by estrogen
3. Effects of transdermal versus oral hormone replacement therapy on bone mineral density in spine and proximal femur in postmenopausal women
4. Continuous combined estrogen/progestin therapy is well tolerated and increases bone density at the hip and spine in postmenopausal osteoporosis
5. Treatment of postmenopausal osteoporosis with transdermal estrogen
6. Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen
7. The effect of postmenopausal estrogen therapy on bone mineral density in elderly women
8. Hormone replacement therapy and risk of breast cancer—results from epidemiologic studies
9. Tamoxifen inhibits osteoclast-mediated resorption of trabecular bone in ovarian hormone-deficient rats
10. Effects of tamoxifen on spinal bone mineral density in women with breast cancer
11. Apparent beneficial effect of tamoxifen on bone mineral content in patients with breast cancer: a preliminary study
12. Effects of tamoxifen on bone mineral content in postmenopausal women with breast cancer
13. Long term effects of tamoxifen. Biological effects of tamoxifen working party
14. Does long-term administration of tamoxifen affect bone mineral density?
15. A pilot trial to assess the acute toxicity and feasibility of tamoxifen for the prevention of breast cancer
16. Estrogenic effects of adjuvant tamoxifen in postmenopausal breast cancer
17. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy
18. Fatal myocardial infarction in the Scottish adjuvant tamoxifen trial. The Scottish Breast Cancer Committee
19. Cardiac and thromboembolic morbidity among postmenopausal women with early stage breast cancer in a randomised trial of adjuvant tamoxifen
20. A simple method of assessing calcium intake in Caucasian women
21. Assessment methods for physical activity and physical fitness in population studies: report of a NHLBI workshop
22. Determinants of total body and regional bone mineral density in normal postmenopausal women—a key role for fat mass
23. Morphologic basis of bone mineral measurements: transient and steady state effects of treatment in osteoporosis
24. Effect of tamoxifen on lumbar spine bone mineral density in postmenopausal women after 5 years
25. Estrogen treatment of patients with established postmenopausal osteoporosis
26. 17β-oestradiol and continuous norethisterone: a unique treatment for established osteoporosis in elderly women
27. Intermittent cyclical etidronate treatment of postmenopausal osteoporosis
28. Continuous therapy with pamidronate, a potent bisphosphonate, in postmenopausal osteoporosis
29. Effect of sequential and daily continuous hormone replacement therapy on indexes of mineral metabolism
30. Mechanisms of 4-hydroxytamoxifen anti-growth factor activity in breast cancer cells: alterations of growth factor receptor binding sites and tyrosine kinase activity
31. Long-term effects of calcium supplementation on bone loss and fractures in postmenopausal women—a randomised controlled trail
32. Effect of calcium supplementation on bone loss in postmenopausal women
33. Risk of endometrial cancer after tamoxifen treatment of breast cancer
34. Effects of raloxifene (LY139481 HCI) on biochemical markers of bone and lipid metabolism in healthy postmenopausal women
35. Hormone therapy to prevent disease and prolong life in postmenopausal women
36. Symptoms associated with tamoxifen treatment in postmenopausal women